EARLY-PHASE STUDY TO EVALUATE MEK AND MDM2 INHIBITION IN PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 AND PREMALIGNANT AND MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
$1,393,487FY2022Department of the ArmyDOD
Children'S Research Institute, Washington DC
Children'S Research Institute, Washington DC